Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2765-2774

  Cheng, Cheng I ^a,b   Hsiao, Chang Chun ^a   Wu, Shinn Chih ^c   Peng, Shao Yu ^c   Yip, Hon Kan ^b   Fu, Morgan ^b   Wang, Feng Sheng ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Akt; Angiogenesis; Angiotensin II; Stem cells

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BUPRENORPHINE; ENHANCED GREEN FLUORESCENT PROTEIN; ISOPROTEIN; PROTEIN KINASE B; SERINE; VALSARTAN; VASCULOTROPIN; WORTMANNIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME SYNTHESIS; GLYCOGEN MUSCLE LEVEL; HINDLIMB; HUMAN; HUMAN CELL; HUMAN TISSUE; ISCHEMIA; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TREATMENT RESPONSE; UMBILICAL VEIN ENDOTHELIAL CELL;

AKT; ANGIOGENESIS; ANGIOTENSIN II; STEM CELLS;

ANGIOGENESIS INHIBITORS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED ICR; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TETRAZOLES; VALINE;

EID: 84883794121     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.128     Document Type: Article

References (45)

1. E.C. Perin, H.F. Dohmann, and R. Borojevic Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure Circulation 107 2003 2294 2302
2. Y.L. Tang, Q. Zhao, and Y.C. Zhang Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium Regul Pept 117 2004 3 10
3. A. Dar, O. Kollet, and T. Lapidot Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice Exp Hematol 34 2006 967 975
4. D. Baksh, J.E. Davies, and P.W. Zandstra Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment Blood 106 2005 3012 3019
5. D.H. Kim, K.H. Yoo, and K.S. Choi Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell Cytokine 31 2005 119 126
6. E.J. Gang, J.A. Jeong, and S. Han In vitro endothelial potential of human UC blood-derived mesenchymal stem cells Cytotherapy 8 2006 215 227
7. T. Kinnaird, E. Stabile, M.S. Burnett, and S.E. Epstein Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences Circ Res 95 2004 354 363
8. D.W. Losordo, and S. Dimmeler Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies Circulation 109 2004 2692 2697
9. W.C. De Mello Heart failure: how important is cellular sequestration? The role of the renin-angiotensin-aldosterone system J Mol Cell Cardiol 37 2004 431 438
10. H.J. Dargie, and J. Byrne Pathophysiological aspects of the renin-angiotensin-aldosterone system in acute myocardial infarction J Cardiovasc Risk 2 1995 389 395
11. R. Donnelly, and G. Manning Angiotensin-converting enzyme inhibitors and coronary heart disease prevention J Renin Angiotensin Aldosterone Syst 8 2007 13 22
12. M. Burnier, and H.R. Brunner Angiotensin II receptor antagonists Lancet 355 2000 637 645
13. K.K. Koh, J.Y. Ahn, and S.H. Han Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients J Am Coll Cardiol 42 2003 905 910
14. M. Akishita, K. Nagai, and H. Xi Renin-angiotensin system modulates oxidative stress-induced endothelial cell apoptosis in rats Hypertension 45 2005 1188 1193
15. A.P. Maggioni Efficacy of angiotensin receptor blockers in cardiovascular disease Cardiovasc Drugs Ther 20 2006 295 308
16. B.I. Levy How to explain the differences between renin angiotensin system modulators Am J Hypertens 18 2005 134S 141S
17. J.S. Silvestre, R. Tamarat, and T. Senbonmatsu Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb Circ Res 90 2002 1072 1079
18. T.G. Ebrahimian, R. Tamarat, and M. Clergue Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice Arterioscler Thromb Vasc Biol 25 2005 65 70
19. G.H. Tang, P.W. Fedak, and T.M. Yau Cell transplantation to improve ventricular function in the failing heart Eur J Cardiothorac Surg 23 2003 907 916
20. T. Kinnaird, E. Stabile, and M.S. Burnett Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 2004 678 685
21. A. Abdel-Latif, R. Bolli, and I.M. Tleyjeh Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis Arch Intern Med 167 2007 989 997
22. J.G. Cleland, N. Freemantle, A.P. Coletta, and A.L. Clark Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE Eur J Heart Fail 8 2006 105 110
23. W.B. Strawn, R.S. Richmond, and E. Ann Tallant Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells Br J Haematol 126 2004 120 126
24. M.A. Ozturk, G.S. Guven, and I.C. Haznedaroglu How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin-angiotensin systems Med Hypotheses 63 2004 866 874
25. K.E. Rodgers, S. Xiong, R. Steer, and G.S. diZerega Effect of angiotensin II on hematopoietic progenitor cell proliferation Stem Cells 18 2000 287 294
26. A. Peister, J.A. Mellad, and B.L. Larson Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential Blood 103 2004 1662 1668
27. D. Ovcharenko, R. Jarvis, and S. Hunicke-Smith High-throughput RNAi screening in vitro: from cell lines to primary cells RNA 11 2005 985 993
28. Y. Miyahara, S. Ohnishi, and H. Obata Beraprost sodium enhances neovascularization in ischemic myocardium by mobilizing bone marrow cells in rats Biochem Biophys Res Commun 349 2006 1242 1249
29. C. Ventura, S. Cantoni, and F. Bianchi Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts J Biol Chem 282 2007 14243 14252
30. T. Kinnaird, E. Stabile, and M.S. Burnett Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms Circulation 109 2004 1543 1549
31. S. Vandervelde, M.J. van Luyn, R.A. Tio, and M.C. Harmsen Signaling factors in stem cell-mediated repair of infarcted myocardium J Mol Cell Cardiol 39 2005 363 376
32. J.S. Silvestre, S. Bergaya, and R. Tamarat Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway Circ Res 89 2001 678 683
33. F. Michel, J.S. Silvestre, and L. Waeckel Thromboxane A2/prostaglandin H2 receptor activation mediates angiotensin II-induced postischemic neovascularization Arterioscler Thromb Vasc Biol 26 2006 488 493
34. R. Tamarat, J.S. Silvestre, and N. Kubis Endothelial nitric oxide synthase lies downstream from angiotensin II-induced angiogenesis in ischemic hindlimb Hypertension 39 2002 830 835
35. K. Sasaki, T. Murohara, and H. Ikeda Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis J Clin Invest 109 2002 603 611
36. V.C. Munk, L. Sanchez de Miguel, and M. Petrimpol Angiotensin II induces angiogenesis in the hypoxic adult mouse heart in vitro through an AT2-B2 receptor pathway Hypertension 49 2007 1178 1185
37. H. Suzuki, K. Eguchi, and H. Ohtsu Activation of endothelial nitric oxide synthase by the angiotensin II type 1 receptor Endocrinology 147 2006 5914 5920
38. L. Armstrong, O. Hughes, and S. Yung The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis Hum Mol Genet 15 2006 1894 1913
39. H.J. Han, J.Y. Han, and J.S. Heo ANG II-stimulated DNA synthesis is mediated by ANG II receptor-dependent Ca(2 +)/PKC as well as EGF receptor-dependent PI3K/Akt/mTOR/p70S6K1 signal pathways in mouse embryonic stem cells J Cell Physiol 211 2007 618 629
40. R.Z. Shi, J.C. Wang, and S.H. Huang Angiotensin II induces vascular endothelial growth factor synthesis in mesenchymal stem cells Exp Cell Res 315 2009 10 15
41. M. Gnecchi, H. He, and N. Noiseux Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J 20 2006 661 669
42. K. Arishiro, M. Hoshiga, and N. Negoro Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits J Am Coll Cardiol 49 2007 1482 1489
43. O. Yoshida, H. Hirayama, and M. Nanasato The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidance Am Heart J 149 2005 e2
44. A. Pourdjabbar, T.G. Parker, and Q.T. Nguyen Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling Am J Physiol Heart Circ Physiol 288 2005 H1997 H2005
45. S. Yusuf, H.C. Diener, and R.L. Sacco Telmisartan to prevent recurrent stroke and cardiovascular events N Engl J Med 359 2008 1225 1237